Skip to main content
Have a personal or library account? Click to login
Efficacy of thyroid cyst sclerotherapy with polidocanol Cover

Efficacy of thyroid cyst sclerotherapy with polidocanol

Open Access
|May 2026

Figures & Tables

FIGURE 1.

Initial and final volume of cysts in three groups of patients with simple thyroid cysts (group (A) – treated with thyroid sclerotherapy with polidocanol; group (B) – treated with ultrasound-guided fine-needle evacuation of the cyst, group (C) – no treatment; x represents mean initial and final cyst volume for each group).

Initial and final cyst volume, initial and final largest cyst diameter, and relative and absolute change in cyst volume

GroupABCp (A:B:C)p (A:B)p (A:C)p (B:C)
Initial cyst volume [mL]20.1 ± 13.8 (2.3-51.1)15.0 ± 17.8 (1.3-83.0)4.2 ± 4.5 (0,8-19,2)< 0.001
Initial largest cyst diameter [mm]41.6 ± 11.4 (23-62)34.4 ± 12.8 (18-65)23.4 ± 6.6 (15-47)< 0.001
Final cyst volume [mL]7.6 ± 12.1 (3.6-11.7)6.1 ± 10.4 (2.8-9.4)5.3 ± 7.9 (2.2-8.3)0.764
Final largest cyst diameter [mm]24.5 ± 15.4 (5-56)21.5 ± 14.3 (4-65)23.2 ± 11.6 (0-55)0.491
Average relative cyst volume difference [%]a-63.5 ± 45.5 (-78.9 to -48.2)-48.2 ± 81.0 (-73.8 to -22.6)8.1 ± 63.6 (-16.6 to 32.8)< 0.0010.318< 0.0010.002
Average nominal cyst volume difference [mL]a12.5 ± 14.7 (7.5-17.4)b8.83 ± 15.6 (3.9-13.7)c-1.0 ± 4.0 (-2.5 to 0.52)< 0.001

Demographic characteristics of the patients and laboratory parameters at the first examination

GroupA (N = 36)B (N = 41)C (N = 28)P
Age [years]46.5 ± 15.851.2 ± 17.465.8 ± 13.7< 0.001
Sex [F/M; % female]20/16 (56%)28/13 (68%)21/7 (75%)0.33
TSH [mIU/L]1.59 ± 1.01.61 ± 0.92.46 ± 2.50.43
fT4 [pmol/L]15.14 ± 1.915.22 ± 2.214.44 ± 2.90.33
fT3 [pmol/L]5.06 ± 0.65.24 ± 0.44.97 ± 0.50.04
Positive antiTg antibodies [%]17.25.612.00.07
Positive antiTPO antibodies [%]12.52.88.00.32
Tg [μg/L]61.55 ± 127.4493.92 ± 2020.026.13 ± 25.150.30

Percentage and absolute number of cysts with a clinically significant change in size according to the criteria of the European Thyroid Association (at least 50% increase or decrease in cyst volume or at least 20% increase or decrease in at least two cyst dimensions)_4

GroupABCp (A:B:C)p (A:B)p (A:C)p (B:C)
Significant decrease of cyst volume (%, absolute number)75.0 (27/36)68.3 (28/41)25.0 (7/28)< 0.0010.616< 0.0010.001
Significant increase of cyst volume (%, absolute number)2.8 (1/36)7.3 (3/41)39.2 (11/28)< 0.001
No significant change in cyst volume (%, absolute number)22.2 (8/36)24.3 (10/41)35.7 (10/28)
DOI: https://doi.org/10.2478/raon-2026-0024 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Submitted on: Oct 11, 2026
Accepted on: Feb 5, 2026
Published on: May 14, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Ziga Mercun, Laura Martinjak, Edvard Pirnat, Simona Gaberscek, Katja Zaletel, Katica Bajuk Studen, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

AHEAD OF PRINT